Click here to read the articles and download the PDF
Although time has welcomed novel advances in the space, new challenges pertaining to data and the physical technology, along with visibility and sustainability, are emerging.
A breakdown of the issues surrounding retail pharmacy—and what can be done to address these difficulties in a timely manner.
Exploring how current and future legislation may impact the role of pharmacy benefit managers (PBMs).
Pharma Pulse 5/6/24: Are Smartphones Driving Teens to Depression? Does Pharma Know What Their Customers Really Want? & more
The latest news for pharma industry insiders.
Astellas, Poseida Therapeutics Ink Allogeneic Cell Therapy Agreement
Collaboration will be oncology based—centered around allogeneic CAR-T cell therapy product candidates—and will provide Poseida with up to $550 million if certain milestones are met.
Teva and Alvotech Further Strengthen Their Relationship, Reach Biosimilar Commercialization Deal
Per the US strategic partnership agreement, the adalimumab high-concentration interchangeable biosimilar will be distributed under the Quallent Pharmaceuticals private label.
Pharma Pulse 5/3/24: Compounded, Counterfeit Semaglutide Poses Severe Risk to Patients, Thermo Fisher Scientific Launches New Testing Service & more
A Look at the Effects of the Inflation Reduction Act
Study explores how the Inflation Reduction Act’s Drug Price Negotiation Program and its maximum fair prices impact incentives for investments in post-approval activity.
Kenco, QPharma Collaborate on Improving Supply Chain Challenges
The partnership revolves around augmenting regulatory compliance, along with drug sampling distribution and compliance.
Pharma Pulse 5/2/24: The Impact of IRA on Drug Prices and Patient Access, Early Communication Crucial for Successful Drug Launch & more
Sygnature Discovery Given Award for Sustainability
The CRO earned a Bronze rating for criteria based on environmental, social, and ethical performance.
Air Freight Demand Continues Its Climb in March
IATA data points to a fourth consecutive month of double-digit, year-on-year growth.
Pharma Pulse 5/1/24: Tailoring AI Regulation in Healthcare, OpenAI and Microsoft Sued Over AI & more
ONO Pharmaceutical Solidifies $2.4 Billion Acquisition of Deciphera
The merger exponentially grows ONO’s oncology pipeline.
Merck KGaA Financially Commits $322 Million Toward Research Center
The complex will research solutions for manufacturing antibodies, mRNA applications, and more.
Pharma Pulse 4/30/24: Advocating For Weight Loss Medication, AI Start-Ups Face Rough Financial Reality Check & more
The Relationship Between Cold Chain Logistics and Cell & Gene Therapies
A one-on-one with Thermo Fisher’s Wilfredo Marin, who dives into the value of ultra-low temperature storage, the need for flexibility in the cold chain logistics space, and more.
Berry Global Increases Manufacturing Capacity
The CDMO’s boost in production will be centered around pharmaceutical products.
Pharma Pulse 4/29/24: Going Beyond Visuals to Connect with Diverse Audiences, Invensify Introduces Energy Efficient Cold Chain Shipping Transporter & more
Examining Drug Shortages Before and During the COVID-19 Pandemic
There is no doubt that drug shortages are a detriment to the pharma supply chain, but how commonplace were they during the COVID era?
Walgreens Debuts Specialty Pharma Business
The move features the launch of an innovation center revolving around cell and gene services.
Pharma Pulse 4/26/24: Amazon Introduces Custom AI Capabilities, Crafting Culturally Sensitive Messages to Reach Diverse Audience & more
Kühne Holding Inks Deal for Aenova
The company adds a top-10 CDMO to its portfolio in the process, while also expanding its commitment to the pharma industry.
Eli Lilly Purchases Nexus Pharmaceutical Injectables Manufacturing Plant
The deal further grows the Big Pharma company’s US production capabilities, especially when it comes to global parenteral products.
Pharma Pulse 4/25/24: Advocate for Greater Pharmacy Technician Roles, Global COVID-19 Vaccines Strategic Research Report 2024 & more
FDA Issues Complete Response Letter to Abeona Therapeutics Regarding PZ-Cel for Recessive Dystrophic Epidermolysis Bullosa
Citing a need for more Chemistry Manufacturing and Controls information, Abeona intends to address the requirements quickly.
Incyte Corporation Inks Deal to Acquire Escient Pharmaceuticals for $750 Million
Deal gives Incyte access to Escient’s pipeline of oral MRGPR antagonists, including EP262 and EP547.
Pharma Pulse 4/24/24: Migraine Treatment Comes in Different Forms, State Level Legislation Impacting Patient Services & more